Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2016-07-14
Target enrollment:
Participant gender:
Summary
This randomized phase I trial studies the side effects and best dose of nanosomal docetaxel
lipid suspension in treating patients with advanced solid tumors. Drugs used in chemotherapy,
such as nanosomal docetaxel lipid suspension, work in different ways to stop the growth of
tumor cells, either by killing the cells or by stopping them from dividing.
Phase:
Phase 1
Details
Lead Sponsor:
University of Southern California
Collaborators:
Jina Pharmaceuticals Inc. Jina Pharmaceuticals, Inc. National Cancer Institute (NCI)